EWA LLC’s SELLAS Life Sciences SLS Stock Holding History

EWA LLC’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$189K	Hold	12,796	–	–	0.03%	312
2026 Q1	$54.1K	Hold	12,796	–	–	0.01%	272
2025 Q4	$48.2K	Buy	+12,796	New	+$24.9K	0.01%	251

Other funds holding SLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

EWA LLC's SLS Position: Q2 2026 in Review

EWA LLC held its SELLAS Life Sciences (SLS) position steady in Q2 2026 at 12,796 shares worth $189K. The position accounts for 0.03% of the portfolio, ranked #312.

EWA LLC first reported a position in SLS in Q4 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

EWA LLC held 12,796 shares of SELLAS Life Sciences worth $189K as of Q2 2026.
EWA LLC left its SELLAS Life Sciences share count unchanged in Q2 2026.
SELLAS Life Sciences made up 0.03% of EWA LLC's portfolio in Q2 2026, its #312 holding.
EWA LLC first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 3 quarters since.
192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on EWA LLC's 13F filing for Q2 2026, filed 14 Jul 2026.